Slow clearance gadolinium-based extracellular and intravascular contrast media for three-dimensional MR angiography

Journal of Magnetic Resonance Imaging

Volumn 13, Issue 4, 2001, Pages 588-593

  Bremerich, Jens ^a   Colet, Jean Marie ^a,b   Giovenzana, Giovanni Battista ^c   Aime, Silvio ^a   Scheffler, Klaus ^a   Laurent, Sophie ^a   Bongartz, Georg ^d   Muller, Robert N ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF MONS   (Belgium)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Extracellular contrast media; Gadolinium chelates; Intravascular contrast media; Myocardial viability; Three dimensional MR angiography

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; CHELATE; CONTRAST MEDIUM; GADOLINIUM; PHENACYL CHLORIDE; WATER;

ARTICLE; CONTRAST ENHANCEMENT; DRUG CLEARANCE; EUROPE; IMAGE QUALITY; IMMUNE RESPONSE; MACROMOLECULE; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; REFERENCE VALUE; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; TISSUE PERFUSION; VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HETEROCYCLIC COMPOUNDS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035077608     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1082     Document Type: Article

References (26)

1. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection
2. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent
3. Characterization of t1 relaxation and blood-myocardial contrast enhancement of NC100150 injection in cardiac MRI
4. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: Preparation and characterization
5. Acute myocardial ischemia and reperfusion: MR imaging with albumin-Gd-DTPA
6. 'NC 100150'. A preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography
7. Steady-state and dynamic MR angiography with MS-325: Initial experience in humans
8. MS-325: Albumin-targeted contrast agent for MR angiography
9. Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC 100150 injection (Clariscan)
10. Contrast-enhanced 3D-TOF MRA of peripheral vessels: Intravascular versus extracellular MR contrast media
11. Safety and preliminary findings with the intravascular contrast agent NC 100150 injection for MR coronary angiography
12. Contrast agent-enhanced, free-breathing, three-dimensional coronary, magnetic resonance angiography
13. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body
14. Gd-DTPA-cascade-polymer: Potential blood pool contrast agent for MR imaging
15. Vascular mapping using albumin-(Gd-DTPA), an intravascular MR contrast agent, and projection MR imaging
16. Renal reabsorption, a new strategy in the developement of vascular contrast agents
17. Novel paramagnetic macromolecular complexes derived from the linkage of a macrocyclic Gd(III) complex to polyamino acids through a squaric acid moiety
18. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer
19. Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: Relevance to MR angiography
20. Transcapillary exchange of 14C-inulin by free diffusion in channels of fused vesicles
21. Reperfused rat myocardium subjected to various durations of ischemia: Estimation of the distribution volume of contrast material with echo-planar MR imaging
22. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: Comparison with 99mTc-DTPA autoradiography in rats
23. Contrast-enhanced MRI for the assessment of myocardial viability, after permanent coronary artery occlusion
24. Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: Further studies at early and late periods of reperfusion
25. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium
26. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: Kinetic modeling in canine ischemic disease